Richard P. Cutts, MD

Specialties: Resident and Surgery

No Patient Experience Reviews – Why Not?

Gundersen Health System requires a minimum of 30 completed patient surveys in a 12-month period for each clinician before posting a clinician’s rating. Industry best practice is clear that more data provides a more accurate picture of the patient experience.

Main Location

La Crosse Campus

1900 South Avenue La Crosse, WI 54601
Office Phone: (608) 775-2331

Profile

Personal Interests

Dr. Cutts was born and raised in Winnipeg, Manitoba, Canada. He moved to the U.S. to attend college, and met his wife, Jacquie, when he applied to go to Uganda for a year with her non-profit organization. They have three spunky children, and as a family enjoy camping, boating, fishing and playing games. In his limited spare time outside of family, Richard enjoys sports, both watching and playing.

After residency, Richard plans on practicing general surgery while prioritizing international work to help in-country providers meet the growing demands of global surgical needs.

Education and Training

College

Brigham Young University

Medical School

Emory University School of Medicine

Residency

Gundersen Medical Foundation

Professional Memberships

American College of Surgeons (ACS)
Association for Academic Surgery (AAS)
Wisconsin Surgical Society (WSS)

Published Works

Bell R, Lipham J, Louie B, et al. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial. Gastrointest Endosc. 2019;89(1):14-22.e1. doi: S0016-5107(18)32848-7 [pii]
Bell R, Lipham J, Louie B, et al. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial. Gastrointest Endosc. 2019;89(1):14-22.e1. doi: S0016-5107(18)32848-7 [pii]
Xu-Monette ZY, Li L, Byrd JC, et al. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. Blood. 2016;128(26):3083-3100. doi: 10.1182/blood-2016-05-715094 [doi]
Chen J, Xu-Monette ZY, Deng L, et al. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. Oncotarget. 2015;6(8):5597-5614. doi: 3343 [pii]
Liu Z, Xu-Monette ZY, Cao X, et al. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Mod Pathol. 2015;28(10):1297-1314. doi: 10.1038/modpathol.2015.94 [doi]
Xu-Monette ZY, Dabaja BS, Wang X, et al. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2015;28(12):1555-1573. doi: 10.1038/modpathol.2015.118 [doi]
Xu-Monette ZY, Tu M, Jabbar KJ, et al. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries. Oncotarget. 2015;6(8):5615-5633. doi: 3479 [pii]
Ok CY, Chen J, Xu-Monette ZY, et al. Clinical implications of phosphorylated STAT3 expression in de novo diffuse large B-cell lymphoma. Clin Cancer Res. 2014;20(19):5113-5123. doi: 10.1158/1078-0432.CCR-14-0683 [doi]
Ok CY, Li L, Xu-Monette ZY, et al. Prevalence and clinical implications of Epstein-Barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res. 2014;20(9):2338-2349. doi: 10.1158/1078-0432.CCR-13-3157 [doi]
Ok CY, Xu-Monette ZY, Tzankov A, et al. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer. 2014;120(12):1818-1829. doi: 10.1002/cncr.28664 [doi]